Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinocort Aqua vs Placebo and Fluticasone in Seasonal Allergic Rhinitis
NCT00641680Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2003
- Primary completion
- Jul 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of budesonide in seasonal allergic rhinitis (SAR), sponsored by AstraZeneca. Started Apr 2003; status: completed.
02
Drugs
budesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00641680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641680.